Status:
COMPLETED
Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
HIV
Hepatitis C
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
End-stage liver disease, predominantly due to hepatitis C virus (HCV) infection, is one of the leading causes of death in person living with HIV infection. While HCV is curable and recent advances in ...
Detailed Description
In response to PAR-12-279 "Pilot Intervention and Services Research Grants (R34)," this application proposes to develop and to test the feasibility, acceptability, and preliminary efficacy of a nurse-...
Eligibility Criteria
Inclusion
- Co-infected with HIV and HCV
- 21 years and older
- Primary language is English or Spanish
- Two most recent HIV RNA levels are both \<1000 copies/mL
- Has attended appointment with HIV PCP in previous 6 months
- Has not attended appointment with HCV Provider in last year
Exclusion
- Presence of active malignancy (except for squamous or basal cell skin cancers), not otherwise in remission
- Chronic kidney disease in hemodialysis or peritoneal dialysis
- Decompensated cirrhosis
Key Trial Info
Start Date :
December 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 28 2017
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT02294136
Start Date
December 1 2013
End Date
April 28 2017
Last Update
May 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029